Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Definium’s LSD therapy has […]
Author: Admin
1 min read
0
GLP-1s in children, Syntis Bio, Vera: Readout Newsletter
National Biotech Reporter Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and […]
1 min read
0
FDA launches pilot program to shorten drug approval times
WASHINGTON — The Food and Drug Administration is opening applications for a pilot program designed to shorten the amount of time it takes for drugmakers to […]
2 min read
0
HHS nominee Chris Klomp faces scrutiny at Senate hearings
WASHINGTON — Over two days, senators on two key committees focused on the authority Chris Klomp already wields, and how he would use this power […]
2 min read
0
After long fight, England to provide AstraZeneca breast cancer drug
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — English […]
2 min read
0
FDA rehiring efforts after DOGE are delayed by original DOGE cuts
WASHINGTON — To hear Food and Drug Administration leaders tell it, everything is going swimmingly — a far cry from the dark days of April […]
1 min read
0
FDA hiring hits bottleneck, Senate holds health hearings
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in […]
1 min read
0
FDA hiring, drug for Parkinson’s symptom, Sella immunotherapy: The Readout
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics […]
1 min read
0
STAT+: Up and down the ladder: The latest comings and goings
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s […]
2 min read
0
Roche, Xenon Pharma, Heidi Overton, Definium: The Readout
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a […]